Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study

Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study

Mamoru Shibata,1 Tomomi Nakamura,2 Akichika Ozeki,2 Kaname Ueda,2 Russell M Nichols3 1Department of Neurology, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Japan; 2Medicines Development Unit Japan and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan; 3Global Medical Affairs, Eli Lilly...

Full description

Bibliographic Details
Main Authors: Shibata M, Nakamura T, Ozeki A, Ueda K, Nichols RM
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Journal of Pain Research
Subjects:
mesh: preventive therapy
quality of life
Online Access:https://www.dovepress.com/migraine-specific-quality-of-life-questionnaire-msq-version-21-score-i-peer-reviewed-article-JPR

Internet

https://www.dovepress.com/migraine-specific-quality-of-life-questionnaire-msq-version-21-score-i-peer-reviewed-article-JPR

Similar Items